Glonghui on May 23 | Novo Nordisk (NVO.US) rose 1.85% to $136.51 in the premarket. At the “2024 Novo Nordisk Headquarters Media Conference” held on May 21, Henrik Wulff, executive vice president and head of product supply, quality and IT at Novo Nordisk, said, “We are continuously increasing our investment in the entire industry chain to meet the market demand for existing products and future products. We focus on providing high quality products to patients around the world in an efficient and environmentally sustainable manner. In production facilities around the world, a number of core production expansion plans are in full swing.”
美股异动丨诺和诺德盘前涨近2% 正推进多项增产扩建计划
Changes in US stocks 丨 Novo Nordisk rose nearly 2% before the market and is advancing a number of plans to increase production and expansion
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.